Lantus solostar 100 unit/ML 3ML
Ended Awarded
- Contract number
- SPE2DB25FH1U1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,924
Award facts
- Contract value 100% obligated
- $1,923.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3mL) with a contract ceiling value of $1,923.70. This firm fixed-price delivery order, which is set to be completed by September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement without a set-aside designation, leveraging AmerisourceBergen's established relationship as a critical pharmaceutical distributor for federal medical supply needs. Performance will occur at the company's corporate office location in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen's comprehensive $999.999 billion prime vendor contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare systems worldwide. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical procurement requirements, from routine pharmaceutical deliveries to specialized healthcare commodities supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular order for insulin reflects the company's critical role in supporting medication access for military personnel and veterans across the global defense medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FH1U1?
SPE2DB25FH1U1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 8, 2025.
How much is contract SPE2DB25FH1U1 worth?
The government has obligated $1,924 on SPE2DB25FH1U1.
Is contract SPE2DB25FH1U1 an order under another contract?
Yes. SPE2DB25FH1U1 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FH1U1 competed?
The extent of competition for SPE2DB25FH1U1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award